CANTEL MEDICAL LLC (CMD) [Rocket]

In millions, except per share items	Jul-31-19	Jul-05-19	Jul-31-18	Jul-31-17	Jul-31-16	Jul-31-15	Jul-31-14	Jul-31-13
	10-K	8-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Medical	523.7		473.9	398.8
Life Sciences	201.0		217.0	196.4
Dental	161.6		149.4	144.5
Dialysis	31.9		31.6	30.5	32.8
Other					632.0
Total revenues [+]	918.2	918.2	871.9	770.2	664.8	565.0	488.7	425.0
Products		918.2			885.5	493.7	434.5	383.5
Services						71.3	54.2	41.5
Revenue growth [+]	5.3%		13.2%	15.9%	17.7%	15.6%	15.0%	10.0%
Medical	10.5%		18.8%
Life Sciences	-7.4%		10.5%
Dental	8.2%		3.4%
Dialysis	0.8%		3.7%	-6.9%
Cost of goods sold [+]	490.7	490.7	458.0	403.0	355.6	311.5	275.5	241.6
Cost of product sales						260.9	236.4	210.4
Cost of services						50.6	39.0	31.1
Gross profit	427.5	427.5	414.0	367.2	309.2	253.5	213.3	183.5
Gross margin	46.6%	46.6%	47.5%	47.7%	46.5%	44.9%	43.6%	43.2%
Selling, general and administrative [+]	312.6	312.6	267.7	238.4	196.5	158.7	131.6	111.0
Sales and marketing	140.2	140.2	129.6	116.1	99.1	80.8	66.5	57.8
General and administrative	172.4	172.4	138.0	122.3	97.5	77.9	65.0	53.2
Research and development	31.3	31.3	24.6	18.4	15.4	14.0	10.8	9.3
Other operating expenses					-0.7	-4.8	0.2	-2.5
EBITDA [+]	125.9	125.9	156.5	143.9	123.0	109.5	89.6	82.9
EBITDA growth	-19.6%		8.8%	16.9%	12.3%	22.2%	8.0%	16.6%
EBITDA margin	13.7%	13.7%	17.9%	18.7%	18.5%	19.4%	18.3%	19.5%
Depreciation	21.5	21.5	17.5	15.0	12.0	10.7	8.2	7.2
EBITA	104.4	104.4	139.0	128.8	111.0	98.8	81.4	75.7
EBITA margin	11.4%	11.4%	15.9%	16.7%	16.7%	17.5%	16.6%	17.8%
Amortization of intangibles	20.8	20.8	17.4	18.4	13.1	13.3	10.6	10.1
EBIT [+]	83.5	83.5	121.7	110.4	97.9	85.6	70.7	65.7
EBIT growth	-31.4%		10.2%	12.7%	14.5%	21.0%	7.7%	19.0%
EBIT margin	9.1%	9.1%	14.0%	14.3%	14.7%	15.1%	14.5%	15.5%
Non-recurring items [+]					0.7	4.8	-0.2	2.5
Loss (gain) on sale of business						2.2
Interest expense, net [+]	9.5	9.5	5.3	4.3	3.3	2.4	2.3	2.8
Interest expense	9.5	9.5	5.3	4.3	3.3	2.4	2.4	2.9
Interest income							0.1	0.1
Other income (expense), net [+]	1.3	1.3	1.1	0.1		-2.2
Other	1.3	-1.3	1.1	0.1
Pre-tax income	75.3	75.3	117.5	106.2	93.9	76.2	68.6	60.4
Income taxes	20.3	20.3	26.5	34.9	34.0	28.2	25.3	21.1
Tax rate	26.9%	26.9%	22.5%	32.8%	36.2%	37.1%	36.9%	35.0%
Net income	55.0	55.0	91.0	71.4	60.0	48.0	43.3	39.2
Net margin	6.0%	6.0%	10.4%	9.3%	9.0%	8.5%	8.9%	9.2%

Basic EPS [+]	$1.32	$1.32	$2.19	$1.72	$1.45	$1.17	$1.06	$0.97
Growth	-39.7%		27.2%	18.7%	24.4%	9.8%	9.0%	23.1%
Diluted EPS [+]	$1.32	$1.32	$2.19	$1.72	$1.45	$1.16	$1.06	$0.97
Growth	-39.7%		27.3%	18.6%	24.5%	10.1%	9.3%	23.6%

Dividends per share [+]	$0.20	$200.00	$0.17	$0.14	$0.12	$0.10	$0.09	$0.07
Growth	17.6%		21.4%	16.7%	20.0%	11.1%	28.6%	16.7%

Shares outstanding (basic) [+]	41.7	41.8	41.6	41.5	41.3	41.1	40.8	40.3
Growth	0.3%		0.2%	0.3%	0.5%	1.0%	1.2%	1.7%
Shares outstanding (diluted) [+]	41.8	41.8	41.6	41.5	41.4	41.2	40.9	40.6
Growth	0.3%		0.2%	0.4%	0.5%	0.7%	0.9%	1.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.